Continuing a cancer treatment despite tumor growth may be valuable: Sunitinib in renal cell carcinoma as example

Mauricio Burotto, Julia Wilkerson, Wilfred Stein, Robert Motzer, Susan Bates, Tito Fojo

Research output: Contribution to journalArticlepeer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'Continuing a cancer treatment despite tumor growth may be valuable: Sunitinib in renal cell carcinoma as example'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science